Skip to main content
. 2018 Oct;9(5):972–978. doi: 10.21037/jgo.2018.08.05

Table 2. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio (N=116).

Variable Mean ± SD Median (range)
Neutrophil to lymphocyte ratio
   Node negative 2.22±1.41 1.78 (0.23–8.20)
   Node positive 5.95±3.69 5.32 (2.27–17.80)
   Metastatic disease 6.51±6.57 4.51 (2.34–36.00)
   Combined 6.18±5.06 4.69 (2.27–36.00)
Platelet to lymphocyte ratio
   Node negative 126.19±46.86 123.03 (14.00–257.69)
   Node positive 278.04±169.54 241.54 (105.45–957.14)
   Metastatic disease 290.82±352.40 196.85 (106.38–2,185.18)
   Combined 283.38±259.95 212.42 (105.45–2,185.18)

, combined equals metastatic disease and node positive patients.